跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 47 条关于
“Cerezen”
全部
47
临床试验
23
药物
5
机构
6
资讯
13
11个月前
Cerezen™ Receives European Approval for Alzheimer's Treatment While U.S. Approval Remains Pending
去年
AbbVie's Emraclidine Fails in Phase II Schizophrenia Trials, Clouding Cerevel Acquisition Value
去年
AbbVie's Emraclidine Fails in Schizophrenia Trials, Impacting Cerevel Acquisition
2年前
Cerevel Therapeutics Advances Emraclidine Development for Alzheimer's-Related Dementia and Psychosis
去年
AbbVie Writes Off $3.5B on Cerevel Drug After Phase 2 Failures
去年
AbbVie's Emraclidine Fails in Phase II Schizophrenia Trials, Shares Plummet
2年前
AbbVie to Acquire Cerevel, Novartis' Fabhalta Approved, and Other Pharma Updates
去年
AbbVie's Schizophrenia Drug Emraclidine Fails in Phase 2 Trials, Impacting Cerevel Acquisition
去年
Genezen and Optieum Partner to Manufacture Lentiviral Vectors for Novel Glioblastoma CAR-T Therapy
去年
PLT Health Solutions' Serezin Shows Significant Sleep and Pain Relief Benefits in Clinical Trial
第 1 页,共 2 页
上一页
下一页